Population genetics and natural selection in the gene encoding the Duffy binding protein II in Iranian Plasmodium vivax wild isolates

Infection, Genetics and Evolution

Volumn 21, Issue , 2014, Pages 424-435

  Valizadeh, Vahideh ^a   Zakeri, Sedigheh ^a   Mehrizi, Akram Abouie ^a   Djadid, Navid Dinparast ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Duffy binding protein; Iran; Natural selection; Plasmodium vivax; Population genetics

Indexed keywords

DNA; DUFFY BINDING PROTEIN; DUFFY BINDING PROTEIN II; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DUFFY ANTIGEN BINDING PROTEIN, PLASMODIUM; EPITOPE; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DBP II GENE; DNA SEQUENCE; ENDEMIC DISEASE; GENE LINKAGE DISEQUILIBRIUM; GENETIC RECOMBINATION; GENETIC SELECTION; GENETIC VARIABILITY; HAPLOTYPE; IMMUNE SYSTEM; IRAN; MALARIA; NATURAL SELECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PHYLOGENY; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNINDEXED SEQUENCE; ADOLESCENT; ADULT; CHEMISTRY; CHILD; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALARIA, VIVAX; MALE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PARASITOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, PROTOZOAN; CHILD; EPITOPES, B-LYMPHOCYTE; FEMALE; GENETIC VARIATION; HUMANS; IRAN; MALARIA, VIVAX; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; PLASMODIUM VIVAX; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; RECOMBINATION, GENETIC; SELECTION, GENETIC; YOUNG ADULT;

EID: 84892645168     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.12.012     Document Type: Article

References (66)

1. Adams J.H., Sim B.K., Dolan S.A., Fang X., Kaslow D.C., Miller L.H. A family of erythrocyte binding proteins of malaria parasites. Proc. Natl. Acad. Sci. USA 1992, 89:7085-7089.
2. Ampudia E., Patarroyo M.A., Patarroyo M.E., Murillo L.A. Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol. Biochem. Parasitol. 1996, 78:269-272.
3. Babaeekho L., Zakeri S., Djadid N.D. Genetic mapping of the Duffy binding protein (DBP) ligand domain of Plasmodium vivax from unstable malaria region in the Middle East. Am. J. Trop. Med. Hyg. 2009, 80:112-118.
4. Baird J.K. Resistance to therapies for infection by Plasmodium vivax. Clin. Microbiol. Rev. 2009, 22:508-534.
5. Balloux F., Lugon-Moulin N. The estimation of population differentiation with microsatellite markers. Mol. Ecol. 2002, 11:55-65.
6. Barnwell J.W., Nichols M.E., Rubinstein P. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J. Exp. Med. 1989, 169:1795-1802.
7. Batchelor J.D., Zahm J.A., Tolia N.H. Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat. Struct. Mol. Biol. 2011, 18:908-914.
8. Cavasini C.E., Mattos L.C., Couto A.A., Bonini-Domingos C.R., Valencia S.H., Neiras W.C., Alves R.T., Rossit A.R., Castilho L., Machado R.L. Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception?. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:1042-1044.
9. Cerávolo I., Souza-Silva F., Fontes C., Braga E., Madureira A., Krettli A., Sousa J., Brito C., Adams J., Carvalho L. Inhibitory properties of the antibody response to Plasmodium vivax Duffy binding protein in an area with unstable malaria transmission. Scand. J. Immunol. 2008, 67:270-278.
10. Chilengi R., Gitaka J. Is vaccine the magic bullet for malaria elimination? A reality check. Malar. J. 2010, 9(Suppl. 3):S1.
11. Chitnis C.E., Miller L.H. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 1994, 180:497-506.
12. Chitnis C.E., Chaudhuri A., Horuk R., Pogo A.O., Miller L.H. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J. Exp. Med. 1996, 184:1531-1536.
13. Chootong P., Ntumngia F.B., VanBuskirk K.M., Xainli J., Cole-Tobian J.L., Campbell C.O., Fraser T.S., King C.L., Adams J.H. Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect. Immun. 2010, 78:1089-1095.
14. Cole-Tobian J.L., Cortés A., Baisor M., Kastens W., Xainli J., Bockarie M., Adams J.H., King C.L. Age-acquired immunity to a Plasmodium vivax invasion ligand, the Duffy binding protein. J. Infect. Dis. 2002, 186:531-539.
15. Cole-Tobian J., King C.L. Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Mol. Biochem. Parasitol. 2003, 127:121-132.
16. Cui L., Escalante A.A., Imwong M., Snounou G. The genetic diversity of Plasmodium vivax populations. Trends. Parasitol. 2003, 19:220-226.
17. Nóbrega de Sousa T., Carvalho L.H., Alves de Brito C.F. Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development. PLoS One 2011, 6:e22944.
18. Dias S., Somarathna M., Manamperi A., Escalante A.A., Gunasekera A.M., Udagama P.V. Evaluation of the genetic diversity of domain II of Plasmodium vivax apical membrane antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka. Vaccine 2011, 29:7491-7504.
19. Fang X., Kaslow D.C., Adams J.H., Miller L.H. Cloning of the Plasmodium vivax Duffy receptor. Mol. Biochem. Parasitol. 1991, 44:125-132.
20. Flück C., Smith T., Beck H.P., Irion A., Betuela I., Alpers M.P., Anders R., Saul A., Genton B., Felger I. Strain-specific humoral response to a polymorphic malaria vaccine. Infect. Immun. 2004, 72:6300-6305.
21. Genton B., Betuela I., Felger I., Al-Yaman F., Anders R.F., Saul A., Rare L., Baisor M., Lorry K., Brown G.V., Pye D., Irving D.O., Smith T.A., Beck H.P., Alpers M.P. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J. Infect. Dis. 2002, 185:820-827.
22. Gething P.W., Elyazar I.R., Moyes C.L., Smith D.L., Battle K.E., Guerra C.A., Patil A.P., Tatem A.J., Howes R.E., Myers M.F., George D.B., Horby P., Wertheim H.F., Price R.N., Müeller I., Baird J.K., Hay S.I. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl. Trop. Dis. 2012, 6:e1814.
23. Gosi P., Khusmith S., Khalambaheti T., Lanar D.E., Schaecher K.E., Fukuda M.M., Miller S.R. Polymorphisms of Plasmodium vivax Duffy binding protein in isolates from Thai patients. Malar. J. 2008, 7:112.
24. Grimberg B., Udomsangpetch R., Xainli J., McHenry A., Panichakul T., Sattabongkot J., Cui L., Bockarie M., Chitnis C., Adams J., Zimmerman P.A., King C.L. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med. 2007, 4:e337.
25. Hans D., Pattnaik P., Bhattacharyya A., Shakri A.R., Yazdani S.S., Sharma M., Choe H., Farzan M., Chitnis C.E. Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol. Microbiol. 2005, 55:1423-1434.
26. Hay S., Guerra C., Tatem A., Noor A., Snow R. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect. Dis. 2004, 4:327-336.
27. Hoffmann E.H., da Silveira L.A., Tonhosolo R., Pereira F.J., Ribeiro W.L., Tonon A.P., Kawamoto F., Ferreira M.U. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2. Ann. Trop. Med. Parasitol. 2001, 95:117-132.
28. Horuk R., Chitnis C., Darbonne W., Colby T., Rybicki A., Hadley T., Miller L. A receptor for the malaria parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993, 261:1182-1184.
29. Ju H.L., Kang J.M., Moon S.U., Kim J.Y., Lee H.W., Lin K., Sohn W.M., Lee J.S., Kim T.S., Na B.K. Genetic polymorphism and natural selection of Duffy binding protein of Plasmodium vivax Myanmar isolates. Malar. J. 2012, 11:60.
30. Ju H.L., Kang J.M., Moon S.U., Bahk Y.Y., Cho P.Y., Sohn W.M., Park Y.K., Park J.W., Kim T.S., Na B.K. Genetic diversity and natural selection of Duffy binding protein of Plasmodium vivax Korean isolates. Acta Trop. 2013, 125:67-74.
31. Jukes T.H., Cantor C.R. Evolution of protein molecules. Mammalian Protein Metabolism 1969, 21-132. Academic Press, New York. H.N. Munro, J.B. Allison (Eds.).
32. Kho W.G., Chung J.Y., Sim E.J., Kim D.W., Chung W.C. Analysis of polymorphic regions of Plasmodium vivax Duffy binding protein of Korean isolates. Korean J. Parasitol. 2001, 39:143-150.
33. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 1980, 16:111-120.
34. King C.L., Michon P., Shakri A.R., Marcotty A., Stanisic D., Zimmerman P.A., Cole-Tobian J.L., Mueller I., Chitnis C.E. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc. Natl. Acad. Sci. USA 2008, 105:8363-8368.
35. Librado P., Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 2009, 25:1451-1452.
36. McHenry A.M., Barnes S.J., Ntumngia F.B., King C.L., Adams J.H. Determination of the molecular basis for a limited dimorphism, N417K, in the Plasmodium vivax Duffy-binding protein. PLoS One 2011, 6:e20192.
37. Ménard D., Barnadas C., Bouchier C., Henry-Halldin C., Gray L.R., Ratsimbasoa A., Thonier V., Carod J.F., Domarle O., Colin Y., Bertrand O., Picot J., King C.L., Grimberg B.T., Mercereau-Puijalon O., Zimmerman P.A. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc. Natl. Acad. Sci. USA 2010, 107:5967-5971.
38. Mendis K., Sina B.J., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2001, 64:97-106.
39. Michon P., Fraser T., Adams J. Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect. Immun. 2000, 68:3164-3171.
40. Miller L.H., Mason S.J., Clyde D.F., McGinniss M.H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 1976, 295:302-304.
41. Mu J., Awadalla P., Duan J., McGee K.M., Keebler J., Seydel K., McVean G.A., Su X.Z. Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome. Nat. Genet. 2007, 39:126-130.
42. Nei M., Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 1986, 3:418-426.
43. Ntumngia F.B., McHenry A.M., Barnwell J.W., Cole-Tobian J., King C.L., Adams J.H. Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development. Am. J. Trop. Med. Hyg. 2009, 80:218-227.
44. Premaratne P.H., Aravinda B.R., Escalante A.A., Udagama P.V. Genetic diversity of Plasmodium vivax Duffy binding protein II (PvDBPII) under unstable transmission and low intensity malaria in Sri Lanka. Infect. Genet. Evol. 2011, 11:1327-1339.
45. Price R.N., Douglas N.M., Anstey N.M. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr. Opin. Infect. Dis. 2009, 22:430-435.
46. Ranjan A., Chitnis C.E. Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins. Proc. Natl. Acad. Sci. USA 1999, 96:14067-14072.
47. Ryan J.R., Stoute J.A., Amon J., Dunton R.F., Mtalib R., Koros J., Owour B., Luckhart S., Wirtz R.A., Barnwell J.W., Rosenberg R. Evidence for transmission of Plasmodium vivax among a Duffy antigen negative population in Western Kenya. Am. J. Trop. Med. Hyg. 2006, 75:575-581.
48. Schoepflin S., Valsangiacomo F., Lin E., Kiniboro B., Mueller I., Felger I. Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping. Malar. J. 2009, 8:250.
49. Shanks G.D. Control and elimination of Plasmodium vivax. Adv. Parasitol. 2012, 80:301-341.
50. Snounou G., Viriyakosol S., Zhu X.P., Jarra W., Pinheiro L., do Rosario V.E., Thaithong S., Brown K.N. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 1993, 61:315-320.
51. Sousa T.N., Cerávolo I.P., Fernandes Fontes C.J., Couto A., Carvalho L.H., Brito C.F. The pattern of major polymorphisms in the Duffy binding protein ligand domain among Plasmodium vivax isolates from the Brazilian Amazon area. Mol. Biochem. Parasitol. 2006, 146:251-254.
52. Sousa T.N., Tarazona-Santos E.M., Wilson D.J., Madureira A.P., Falcāo P.R., Fontes C.J., Gil L.H., Ferreira M.U., Carvalho L.H., Brito C.F. Genetic variability and natural selection at the ligand domain of the Duffy binding protein in Brazilian Plasmodium vivax populations. Malar. J. 2010, 9:334.
53. Souza-Silva F.A., da Silva-Nunes M., Sanchez B.A., Ceravolo I.P., Malafronte R.S., Brito C.F., Ferreira M.U., Carvalho L.H. Naturally acquired antibodies to Plasmodium vivax Duffy binding protein (DBP) in Brazilian Amazon. Am. J. Trop. Med. Hyg. 2010, 82:185-193.
54. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989, 123:585-595.
55. Takala S.L., Plowe C.V. Genetic diversity and malaria vaccine design, testing, and efficacy: preventing and overcoming "vaccine resistant malaria". Parasite Immunol. 2009, 31:560-573.
56. Tjitra E., Anstey N.M., Sugiarto P., Warikar N., Kenangalem E., Karyana M., Lampah D.A., Price R.N. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLOS Med. 2008, 5:e128.
57. Tran T.M., Oliveira-Ferreira J., Moreno A., Santos F., Yazdani S.S., Chitnis C.E., Altman J.D., Meyer E.V., Barnwell J.W., Galinski M.R. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. Am. J. Trop. Med. Hyg. 2005, 73:244-255.
58. Tsuboi T., Kappe S.H., al-Yaman F., Prickett M.D., Alpers M., Adams J.H. Natural variation within the principal adhesion domain of the Plasmodium vivax Duff binding protein. Infect. Immun. 1994, 62:5581-5586.
59. VanBuskirk K.M., Sevova E., Adams J.H. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc. Natl. Acad. Sci. USA 2004, 101:15754-15759.
60. VanBuskirk K.M., Cole-Tobian J.L., Baisor M., Sevova E.S., Bockarie M., King C.L., Adams J.H. Antigenic drift in the ligand domain of Plasmodium vivax Duffy binding protein confers resistance to inhibitory antibodies. J. Infect. Dis. 2004, 190:1556-1562.
61. Volkman S.K., Ndiaye D., Diakite M., Koita O.A., Nwakanma D., Daniels R.F., Park D.J., Neafsey D.E., Muskavitch M.A., Krogstad D.J., Sabeti P.C., Hartl D.L., Wirth D.F. Application of genomics to field investigations of malaria by the international centers of excellence for malaria research. Acta Trop. 2012, 121:324-332.
62. Wertheimer S.P., Barnwell J.W. Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. Exp. Parasitol. 1989, 69:340-350.
63. White N.J. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar. J. 2011, 10:297.
64. Xainli J., Adams J.H., King C.L. The erythrocyte binding motif of Plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. Mol. Biochem. Parasitol. 2000, 111:253-260.
65. Xainli J., Cole-Tobian J.L., Baisor M., Kastens W., Bockarie M., Yazdani S.S., Chitnis C.E., Adams J.H., King C.L. Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein. Infect. Immun. 2003, 71:2508-2515.
66. Yang Z.R., Thomson R., McNeil P., Esnouf R.M. RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 2005, 21:3369-3376.